Pfizer Inc. (NYSE: PFE) Q2 2021 Earnings call dated Jul. 28, 2021
Corporate Participants:
Christopher Stevo — Senior Vice President, Chief Investor Relations Officer
Albert Bourla — Chairman and Chief Executive Officer
Mikael Dolsten — Chief Scientific Officer and President, Worldwide Research, Development and Medical
Frank DAmelio — Chief Financial Officer
Angela Hwang — Group President, Pfizer Biopharmaceuticals Group
Analysts:
Kerry Holford — Berenberg — Analyst
Matthew Harrison — Morgan Stanley — Analyst
Daniel Bisbee — RBC Capital — Analyst
Chris Schott — J.P. Morgan — Analyst
Ronny Gal — Bernstein — Analyst
Geoff Meacham — Bank of America — Analyst
Andrew Baum — Citi — Analyst
Carter Gould — Barclays — Analyst
Geoffrey Porges — SVB Leerink — Analyst
Louise Chen — Cantor — Analyst
Terence Flynn — Goldman Sachs — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q3 2024
Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to
Key highlights from Exxon Mobil Corporation’s (XOM) Q3 2024 earnings results
Exxon Mobil Corporation (NYSE: XOM) reported its third quarter 2024 earnings results today. Total revenues and other income remained relatively flat at $90 billion compared to the same period a
AAPL Earnings: Apple Q4 2024 sales rise 6% YoY, beat estimates
Apple Inc. (NASDAQ: AAPL) reported an increase in revenues for the fourth quarter of 2024. The top line came in above estimates. The gadget giant generated revenues of $94.9 billion
Listen On
